Literature DB >> 15292890

Failure rates in nonlatex surgical gloves.

Denise M Korniewicz1, Laurel Garzon, Judy Seltzer, Manning Feinleib.   

Abstract

BACKGROUND: The purpose of this study was to compare the frequency of glove defects for nonlatex surgical gloves while surgeons performed routine surgery and to evaluate surgeons' satisfaction with nonlatex sterile gloves.
METHODS: Two brands of latex gloves and 6 brands of nonlatex gloves were tested. Gloves were collected at the end of each surgical procedure and tested for visual defects and barrier integrity using an automated calibrated water test machine consistent with FDA's recommended standards. A total of 6386 gloves used by 101 surgeons and 164 residents representing 15 surgical services were included in the analysis.
RESULTS: Higher after-use defect rates occurred in nonlatex surgical gloves than in latex gloves. Higher times of use were related to higher defect rates for some surgical specialties, and both surgeons and residents were less satisfied with nonlatex surgical gloves.
CONCLUSION: Intact latex and nonlatex surgical gloves provide adequate barrier protection. Nonlatex surgical gloves have higher failure rates and lower user satisfaction than latex gloves do. Both nonlatex and latex gloves should be changed after 2 to 3 hours of use because the barrier of either type of glove becomes compromised with extended use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292890     DOI: 10.1016/j.ajic.2003.12.005

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  2 in total

1.  Performance analysis of exam gloves used for aseptic rodent surgery.

Authors:  Dana M LeMoine; Valerie K Bergdall; Carrie Freed
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-05       Impact factor: 1.232

2.  Integrity of disposable nitrile exam gloves exposed to simulated movement.

Authors:  Robert N Phalen; Weng Kee Wong
Journal:  J Occup Environ Hyg       Date:  2011-05       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.